Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Effexor® SR 37.5 mg / 75 mg capsules (venlafaxine ...
Medscape

Confirmed: Antidepressants Effective for Generalized Anxiety Disorder

A new Cochrane review confirmed that antidepressants, including selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline reuptake inhibitors (SNRIs), are superior to placebo in ...

Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion

Market News Updates News Commentary - Treatments for Generalized Anxiety Disorder (GAD) are getting better and more accessible, which is good news for millions of people dealing with constant worry ...
New York Post

How Josh Gad became a comic sensation despite lifetime of anxiety and self-doubt

Consider that after a lifetime of acting lessons, four years of drama school at Carnegie Mellon, and three years after college of booking only one professional gig (a single episode of “ER”), the ...